October 30, 2016Imsang soa hyeoraek jong-yang/Imsang soa hyeol'aeg jong'yang/Clinical pediatric hematology-oncologyOpen Access

Propranolol as a First-line Treatment for Pediatric Hemangioma: Outcome of a Single Institution Over One Year

View Full Paper

Ask AI

Bookmark

Abstract

Propranolol as a First-line Treatment for Pediatric Hemangioma: Outcome of a Single Institution Over One Year Kyung Moon Kim, M.D., Dong Hoon Min, M.D., Hye Lim Jung, M.D., Jae Won Shim, M.D., Deok Su Kim, M.D., Jung Yeon Shim, M.D., Moon Soo Park, M.D., Hee Jin Park, M.D. and So Yeon Lee, M.D. Departments of Pediatrics, Radiology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kim et al. (2016) studied this question.

synapsesocial.com/papers/6ac47214f8151bbe24204369 https://doi.org/10.15264/cpho.2016.23.2.97

View Full Paper

Ask AI

Bookmark

Propranolol as a First-line Treatment for Pediatric Hemangioma: Outcome of a Single Institution Over One Year

Abstract

Discussion

Cite This Study

Propranolol as a First-line Treatment for Pediatric Hemangioma: Outcome of a Single Institution Over One Year

Abstract

Discussion

Cite This Study

Keep reading

Keep reading